Russia will start giving its first drug approved to treat COVID-19 to patients next week

Russia's temporary approval for Avifavir to treat COVID-19

Russia, which is the third-worst affected country by coronavirus, is planning to start clinical trials within two weeks on a vaccine to combat the coronavirus, the health minister reported on Saturday.

COVID 19: Russia to start vaccine trials within two weeks

avifavir

Avifavir, News on Avifavir, stories on Avifavir, articles on Avifavir, Avifavir stories at Wion, Avifavir news, Avifavir latest news